• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Dynamic shifts management, Assif replaces Laskey at helm

Article

Dynamic Healthcare Technologies is one of the many health IT companies shuffling top management in an effort to compensate for tougher market conditions. Mitch Laskey, who founded Dynamic and has served as its president and CEO, has stepped

Dynamic Healthcare Technologies is one of the many health IT companies shuffling top management in an effort to compensate for tougher market conditions. Mitch Laskey, who founded Dynamic and has served as its president and CEO, has stepped aside to become a consultant to the company. Christopher Assif, formerly president of Dynamic's Internet Solutions group, has replaced Laskey as CEO. John Fingado, formerly vice president and general manager of CoPath, has been appointed president and COO. Dynamic will concentrate its marketing on the CoMed product suite, which offers clinical connectivity and ASP-based products for laboratory, pathology, and radiology departments.

In related news, Dynamic has expanded the size of its board to seven members from five. Assif and Christopher Cooper, president of Plangent Systems and cofounder of Collaborative Medical Systems (a company acquired by Dynamic in 1996), are the newest appointees. Laskey has retained his seat on the board of directors.


© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.